Heterocyclic molecules have fascinated a massive interest in medicinal chemistry. They are heterocyclic compounds that have gained significance due to their diverse variety of pharmacological activities. Benzimidazole is a heterocyclic compound consisting of benzene and imidazole rings. The ease of synthesis and the structural versatility of benzimidazole make it a promising scaffold for drug development. Many biological actions of benzimidazole derivatives have been well documented, including antibacterial, antiviral, anticancer, anti-inflammatory, antitubercular, and anthelmintic properties. The mechanism of action of benzimidazole derivatives varies with their chemical structure and target enzyme. This review has explored numerous methods for producing benzimidazole derivatives as well as a broad range of pharmacological activities. SAR investigations are also discussed in this review as they provide crucial details regarding the essential structural qualities that benzimidazole derivatives must have in order to be biologically active, which could aid in the rational design of new drug candidates. : Benzimidazole scaffold is an exclusive structure in drug design and discovery. Many new pharmaceutical drugs containing benzimidazole are anticipated to be available within the next ten years as a result of the extensive therapeutic applications of benzimidazole and its derivatives. This review inspired many researchers to develop more biologically active compounds bearing benzimidazole, expanding the scope of finding a remedy for other diseases. From this study, we concluded that 2-substituted benzimidazole was considered more extensively by researchers.
CADD is an important aspect of the any currently employed drug discovery process for a medicinal chemist. In the current study, research was initiated with a two dimensional Quantitative Structural Activity Relationship (QSAR) model generation through previously synthesized compounds. The 2-D QSAR model generated is then engaged for the predicting of the activity of our proposed compounds to be synthesized. This ligand-based approach of computer aided drug designing (CADD) is complimented further with the molecular docking simulations. Molecular docking of our proposed compounds was done to study the interaction of these compounds with the target protein i.e. tyrosine kinase receptor. Almost all the compounds showed significant results. Among them the most potent compound is SSIV which has -11.8 K/Cal/Mole.
Autism spectrum disorder (ASD) is a complex neurological state that is marked by difficulties skills and interactions, alongside iterative behaviours and limiting interests. ASD affects around one in the US; one out of every 54 children have a diagnosis. usually coming in early infancy following full assessments by multidisciplinary teams. ASD symptoms vary greatly and are typically shown in two areas: social communication problems and repetitive behaviour. While the actual origins of ASD are unknown, evidence indicates a mix of genetic predispositions and environmental variables. Early intervention with occupational therapy, speech and language therapy and behavioural therapies and support for education is essential for better outcomes. Recent advancements in genetic research, neuroimaging and the growth of innovative ways to treat show promise for improving the understanding and management of ASD. This review seeks to present a complete picture of ASD, including its symptoms, causes and current and developing therapy. It also stresses the need for continued research and raising awareness to help those affected and their families.